GGrantIndex
← Search

Leadership, Planning and Evaluation

$372,407P30FY2025CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

Senior leadership for Roswell Park Cancer Comprehensive Cancer Center works collaboratively to implement critical planning and evaluation processes that include recruitment efforts, research initiatives, clinical trial growth, educational programs, and operational objectives as outlined in the strategic plan responsive to our catchment area. Candace Johnson (DT), as the CCSG Director and President and CEO of Roswell Park, has ultimate authority over space allocation, finances, strategic initiatives, and clinical and scientific operations. She is joined on the CCSG leadership team by Renier Brentjens (TII) as Deputy Director and eight Associate Directors, who collectively possess valuable experience that encompasses all aspects of basic, clinical cancer research, cancer prevention and control, cancer education and training and community outreach. Completed in 2023, the CCSG strategic planning process culminated in a dynamic strategic plan built with input from both programmatic and senior leadership. The strategic plan includes key objectives to ensure the continued delivery of exceptional scientific research, education and clinical care and is directly responsive to community partner recommendations. Business planning metrics and benchmarks were incorporated to provide the senior leadership team with effective mechanisms to continually evaluate success. Leadership, planning and evaluation efforts rely upon key internal advisory committees, community members, and external advisory boards, which inform leadership about important local, regional and national issues impacting the cancer center. There are 4 main committees that provide input into strategic decision making: 1) The bi-weekly Strategic Council meeting that includes both senior leadership of the cancer center and the Associate Directors, 2) the monthly CCSG Steering Committee with Associate Directors, Program Leaders, select Shared Resource Directors, and other contributors to set directions for cancer center planning. 3) The annual External Advisory Board meetings which provide critical feedback and guidance regarding programmatic direction, shared resources and research progress. In addition, individual program advisory boards meet every 12 months and help guide decisions on revisions to programmatic aims and ways to foster community engagement. And 4) the Community Advisory Board which meets quarterly to discuss catchment-level issues impacting the broader community around the medical campus as well as to guide the programmatic direction of the center as it relates to the community. In addition to these 4 main committees, the Associate Directors lead committees to engage faculty in their specialty areas to ensure there is bi-directional communication occurring among all levels of the cancer center. At its core, leadership, planning and evaluation are the foundational ingredients that have and will continue to drive Roswell Park to achieving its strategic goals in the upcoming renewal period.

View original record on NIH RePORTER →